Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Tenormin, Apo-Atenol, Atenolol Cinfa (Show all)
Atenolol, a beta blocker, is used to treat hypertension, alone or in combination with other agents. Off label use for acute alcohol withdrawal, certain cardiac arrhythmias, and prevention of migraine headache.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Elevated blood pressure | 150 | 29 |
|
|
|
||
| Other | 72 | 11 |
|
|
|
||
| Hypertension | 29 | 5 |
|
|
|
||
| Tachycardia (fast heart rate) | 29 | 11 |
|
|
|
||
| General health | 21 | 4 |
|
|
|
||
| Heart palpitations | 18 | 4 |
|
|
See all 419 patients currently taking Atenolol
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Atenolol
| Fatigue | 12 | |
|---|---|---|
| Slowed heart rate | 6 | |
| Tiredness | 6 | |
| Generalized weakness (asthenia) | 6 | |
| Dizziness | 4 | |
| Pain in legs | 3 | |
| See all 22 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Atenolol. See all 23 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 30 | ||
| Side effects too severe | 14 | ||
| Other | 11 | ||
| Did not seem to work | 7 | ||
| Not indicated | 5 | ||
| Personal research | 3 | ||
| Course of treatment ended | 3 |
Adherence
Taking treatment as prescribed
Adherence of Atenolol
Always |
84 | 92% |
|
|---|---|---|---|
Usually |
6 | 7% |
|
Sometimes |
0 | 0% |
|
Never |
1 | 1% |
|
Burden
Difficulty being on treatment
Burden of Atenolol
Very |
3 | 3% |
|
|---|---|---|---|
Somewhat |
2 | 2% |
|
A little |
7 | 8% |
|
Not at all |
79 | 87% |
|
Cost
Paid out of pocket
Cost of Atenolol
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
2 | 3% |
|
< $25 |
60 | 97% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on February 11, 2012.